halofuginone has been researched along with Carcinoma, Lewis Lung in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, Y; Gong, L; Hou, H; Ji, K; Liu, N; Liu, W; Wang, P; Wang, Y; Zhao, L | 1 |
1 other study(ies) available for halofuginone and Carcinoma, Lewis Lung
Article | Year |
---|---|
Halofuginone inhibits radiotherapy-induced epithelial-mesenchymal transition in lung cancer.
Topics: Animals; Antineoplastic Agents; Benzamides; Carcinoma, Lewis Lung; Cell Movement; Dioxoles; Epithelial-Mesenchymal Transition; Female; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Piperidines; Quinazolinones; Smad Proteins; Transforming Growth Factor beta1; Xenograft Model Antitumor Assays | 2016 |